The Case: What We Know
Between 2008 and 2015, a donor’s sperm was used by fertility clinics to conceive dozens of children throughout Europe. Unknown at the time, the donor carried a rare TP53 gene variant—now linked to Li-Fraumeni syndrome, one of the most severe inherited predispositions to cancer.
At the time of donation, this specific variant was not known to be dangerous and would not have been detected through standard donor screening. The donor remains healthy. However, once several children developed cancer, two families contacted their clinics. Genetic investigations followed, revealing that 23 children inherited the mutation, and 10 have been diagnosed with cancers including leukaemia and non-Hodgkin lymphoma.
Why This Matters
The case spotlights a major vulnerability in the global fertility system: the absence of unified international limits on the number of families or children conceived by a single donor. In countries with no strict regulation—or when sperm is shipped across borders—there is a risk of genetic issues being replicated on a large scale before problems are even detected.
Dr. Edwige Kasper, who investigated the case, said: “This is the abnormal dissemination of genetic disease. Not every man has 75 children across Europe.”
She warned that the situation makes it extremely difficult to trace and notify affected families once a genetic issue becomes known.
A Widespread Concern Across Europe
So far, the European Sperm Bank has acknowledged that the donor fathered more than 67 children but declined to disclose an exact number. Their self-imposed limit is 75 families per donor, but experts argue this is far too high—particularly in light of the medical and psychological risks involved.
Professor Nicky Hudson, of De Montfort University, explained: “This case highlights the difficulty of tracing donor-conceived families when gametes are shipped internationally. Even when national limits exist, they become meaningless once sperm is used in multiple countries.”
Pride Angel’s 10-Family Policy: A Proactive Approach
In response to concerns like these, Pride Angel has long advocated for stricter donor limits. The platform works to maintain a 10-family maximum per donor, a significantly lower threshold than most sperm banks.
This limit is in place not only to reduce medical risk in cases where late-onset genetic conditions may emerge, but also to:
-
Preserve genetic diversity, especially in local populations
-
Avoid accidental consanguinity among donor-conceived individuals
-
Enable easier contact tracing in the event of medical issues
-
Promote transparency and trust in known donor arrangements
By enabling individuals and couples to connect with donors directly, Pride Angel also supports ongoing dialogue between donors and recipients—something that can prove critical if medical concerns arise years later.
What Needs to Change?
The case has led many experts to call for:
-
An internationally mandated limit on the number of families per donor
-
A central registry to track donor use across borders
-
Improved protocols for sharing health alerts with families
-
Clearer regulations for gamete export and import
Julie Paulli Budtz of the European Sperm Bank said the donor had been thoroughly tested and that it is “scientifically simply not possible to detect disease-causing mutations if you don’t know what you’re looking for.” However, she added that the bank “welcomes continued dialogue on setting a family limit” and has implemented its own policy of 75 families per donor.
Conclusion
This troubling case is a stark reminder that donor conception isn’t just about creating life—it’s about safeguarding it. While such incidents remain rare, the consequences are too severe to ignore. With sperm donation increasingly globalized, experts, clinics, regulators, and donor platforms like Pride Angel agree: we need stricter international coordination, lower family limits, and better tracking systems to protect future families and ensure ethical fertility practices worldwide.